{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "67046-0637",
      "generic_name": "quetiapine",
      "labeler_name": "Coupler LLC",
      "brand_name": "Quetiapine fumarate",
      "active_ingredients": [
        {
          "name": "QUETIAPINE FUMARATE",
          "strength": "200 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "67046-0637-3",
          "description": "30 TABLET in 1 BLISTER PACK (67046-0637-3)",
          "marketing_start_date": "20260526",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Coupler LLC"
        ],
        "rxcui": [
          "317174"
        ],
        "spl_set_id": [
          "52ba669d-c846-03c2-e063-6394a90ac0f0"
        ],
        "unii": [
          "2S3PL1B6UJ"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "52ba72f2-e3a4-89d2-e063-6294a90aa496",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260526",
      "product_id": "67046-0637_52ba72f2-e3a4-89d2-e063-6294a90aa496",
      "application_number": "ANDA201109",
      "brand_name_base": "Quetiapine fumarate",
      "pharm_class": [
        "Atypical Antipsychotic [EPC]"
      ]
    }
  ]
}